Results 221 to 230 of about 1,293,835 (325)

Essential work, invisible workers: The role of digital curation in COVID‐19 Open Science

Journal of the Association for Information Science and Technology, Volume 76, Issue 4, Page 703-717, April 2025.
Abstract In this paper, we examine the role digital curation practices and practitioners played in facilitating open science (OS) initiatives amid the COVID‐19 pandemic. In Summer 2023, we conducted a content analysis of available information regarding 50 OS initiatives that emerged—or substantially shifted their focus—between 2020 and 2022 to address ...
Irene V. Pasquetto, Amina A. Abdu, Natascha Chtena   +2 more
wiley   +1 more source

Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis

Man Ting Au, Junguo Ni, Kaiming Tang, Wei Wang, Lanlan Zhang, Hantang Wang, Fangyi Zhao, Zhan Li, Peng Luo, Lawrence Chun‐Man Lau, PK Chan, Cuiting Luo, Bo Zhou, Lin Zhu, Charlie Yuli Zhang, Tianshu Jiang, Marianne Lauwers, Jasper Fuk‐Woo Chan, Shuofeng Yuan, Chunyi Wen   +19 more
openalex   +2 more sources

Keeping the Fire House Running: A Proposed Approach to Mitigate Spread of COVID-19 Among Public Safety Personnel [PDF]

, 2020
Katzer, Robert J.
core  

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

De N ovo -Designed Miniprotein Inhibits the Enzymatic Activity of the SARS-CoV-2 Main Protease

Tayná Evily de Lima, Emerson G. Moreira, Danilo F. Coêlho, Carlos Cruz, Rafael Dhália, Bruno Leite, Lícya S.S. Xavier, Marta Illana, Gabriel Luz Wallau, Isabelle F. T. Viana, Roberto D. Lins   +10 more
openalex   +1 more source

Metadichol®, A Novel Nano Lipid Formulation that Inhibits SARS-CoV-2 and a Multitude of Pathological Viruses in Vitro

, 2020
Palayakotai R Raghavan
openalex   +1 more source

Decision letter: Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects

, 2023

openalex   +1 more source

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Nature Medicine, 2020
Quan-xin Long, Xiao-jun Tang, Qiuling Shi, Qin Li, H. Deng, Jun Yuan, Jie-Li Hu, W. Xu, Yong Zhang, Fa-jin Lv, K. Su, Fan Zhang, Jiang Gong, Bo Wu, Xia-mao Liu, Jin-jing Li, Jing-Fu Qiu, Juan Chen, A. Huang   +18 more
semanticscholar   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel, Christine van Linge, W. Joost Wiersinga, Ilse J. E. Kouijzer, Quirijn de Mast, Robert‐Jan Hassing, Danique J. H. Huijbens, Helen L. Leavis, Roger Schutgens, Coen Maas, Kit C. B. Roes, Frank L. van de Veerdonk, Roger Brüggemann   +12 more
wiley   +1 more source

Development of Schamberg's disease after SARS‐CoV‐2 vaccination

Journal of Cutaneous Immunology and Allergy, 2022
Hiroki Morimoto, Yasuaki Ogura, Masaki Otsuka, Satoshi Hayano, Yoshiki Tokura   +4 more
doaj   +1 more source